Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Walsh

Showing results (911-920 of 931) with videos related to

Pageof 94
Sort By:
Plos One|July 13, 2026
Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adultsDaniel P Croft, Md Rayhanul Islam, Kelly Thevenet-Morrison, et al.
Nature|August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
The New England Journal of Medicine|October 14, 2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy StudyEdward E Walsh, Robert Frenck, Ann R Falsey, et al.
Immunity|July 19, 2015
Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone MarrowJessica L Halliley, Christopher M Tipton, Jane Liesveld, et al.
Molecular Neurodegeneration|September 7, 2021
APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysisBrandon C Farmer, Holden C Williams, Nicholas A Devanney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2017
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of VaccinesLindsay Kim, Brian Rha, Jon S Abramson, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|December 13, 2023
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older AdultsEleanor Wilson, Jaya Goswami, Abdullah H Baqui, et al.
Pageof 94

Showing results (911-920 of 931) with videos related to

Sort By:
Pageof 94
Plos One|July 13, 2026
Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adultsDaniel P Croft, Md Rayhanul Islam, Kelly Thevenet-Morrison, et al.
Nature|August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
The New England Journal of Medicine|October 14, 2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy StudyEdward E Walsh, Robert Frenck, Ann R Falsey, et al.
Immunity|July 19, 2015
Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone MarrowJessica L Halliley, Christopher M Tipton, Jane Liesveld, et al.
Molecular Neurodegeneration|September 7, 2021
APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysisBrandon C Farmer, Holden C Williams, Nicholas A Devanney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2017
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of VaccinesLindsay Kim, Brian Rha, Jon S Abramson, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|December 13, 2023
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older AdultsEleanor Wilson, Jaya Goswami, Abdullah H Baqui, et al.
Pageof 94